Premières journées nationales de pharmacodépendance (CEIP). Place de la pharmacodépendance dans l'évaluation du médicament
Thérapie, 63 1 (2008) 55-65
Publié en ligne : 2008-04-04
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol
Marie Gérardin, Morgane Rousselet, Pascal Caillet, Marie Grall-Bronnec, Pierre Loué, Pascale Jolliet and C Victorri-VigneauBMJ Open 9 (6) e027443 (2019)
https://doi.org/10.1136/bmjopen-2018-027443
Parachuting: a dangerous trend in recreational psychoactive substance delivery
David Boels, Marie Grall-Bronnec, Marylène Guerlais, et al.Expert Opinion on Drug Delivery 14 (4) 491 (2017)
https://doi.org/10.1080/17425247.2016.1222371
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey
Amélie Daveluy, Elisabeth Frauger, Hélène Peyrière, Christophe Moracchini, Françoise Haramburu and Joëlle MicallefFundamental & Clinical Pharmacology 31 (1) 126 (2017)
https://doi.org/10.1111/fcp.12233
Multicentre study for validation of the French addictovigilance network reports assessment tool
Caroline Victorri‐Vigneau, Jean Benoit Hardouin, Morgane Rousselet, Marie Gerardin, Marylène Guerlais, Morgane Guillou, Marie Bronnec, Véronique Sébille and Pascale JollietBritish Journal of Clinical Pharmacology 82 (4) 1030 (2016)
https://doi.org/10.1111/bcp.13044
Un exemple d’évaluation de l’abus et de la dépendance en addictovigilance : à propos du tramadol
Anne Roussin, Odile Doazan d’Ouince, Hélène Géniaux and Clémence HalbererTherapies 70 (2) 203 (2015)
https://doi.org/10.2515/therapie/2014221
Signal Identification in Addictovigilance: the Functioning of the French System
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie DaveluyTherapies 70 (2) 123 (2015)
https://doi.org/10.2515/therapie/2015011
Système de surveillance en addictovigilance : quelles données pharmacoépidémiologiques à l'échelle de l'Europe ?
Maryse Lapeyre-Mestre and Mathilde DupuiTherapies 70 (2) 147 (2015)
https://doi.org/10.2515/therapie/2015006
Un exemple d’investigation d’un phénomène « émergent » en addictovigilance : à propos du méthylphénidate
Joëlle Micallef, Elisabeth Frauger, Aurore Palmaro, Quentin Boucherie and Maryse Lapeyre MestreTherapies 70 (2) 191 (2015)
https://doi.org/10.2515/therapie/2015012
Example of an Investigation of an “Emergent” Phenomenon in Addiction Vigilance: the Case of Methylphenidate
Joëlle Micallef, Elisabeth Frauger, Aurore Palmaro, Quentin Boucherie and Maryse Lapeyre MestreTherapies 70 (2) 197 (2015)
https://doi.org/10.2515/therapie/2015013
Evaluation of Abuse and Dependence in Addiction Monitoring Systems: Tramadol as an example
Anne Roussin, Odile Doazan-d’Ouince, Hélène Géniaux and Clémence HalbererTherapies 70 (2) 213 (2015)
https://doi.org/10.2515/therapie/2015014
Drug Abuse Monitoring: Which Pharmacoepidemiological Resources at the European Level?
Maryse Lapeyre-Mestre and Mathilde DupuiTherapies 70 (2) 157 (2015)
https://doi.org/10.2515/therapie/2015010
Comment identifier un signal en addictovigilance ?
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie DaveluyTherapies 70 (2) 113 (2015)
https://doi.org/10.2515/therapie/2015009
Designing a tool allowing for a standardized assessment of resistance to drug diversion
Caroline Victorri-Vigneau, Cedric Collin, Catherine Messina-Gourlot, et al.Expert Opinion on Drug Delivery 11 (7) 995 (2014)
https://doi.org/10.1517/17425247.2014.901307
French Specific Surveillance System for Drug Abuse
Elisabeth Frauger, Christophe Moracchini, Françoise Albertini, Xavier Thirion and Joëlle MicallefInternational Journal of Mental Health 43 (3) 49 (2014)
https://doi.org/10.1080/00207411.2014.1003741
Slow-Release Oral Morphine Sulfate Abuse: Results of the Postmarketing Surveillance Systems for Psychoactive Prescription Drug Abuse in France
Hélène Peyriere, Céline Eiden, Joëlle Micallef, Maryse Lapeyre-Mestre, Jean-Luc Faillie and Jean-Pierre BlayacEuropean Addiction Research 19 (5) 235 (2013)
https://doi.org/10.1159/000346179
OPPIDUM surveillance program: 20 years of information on drug abuse in France
Elisabeth Frauger, Christophe Moracchini, Reynald Le Boisselier, David Braunstein, Xavier Thirion and Joëlle MicallefFundamental & Clinical Pharmacology 27 (6) 672 (2013)
https://doi.org/10.1111/fcp.12024
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage
Caroline Victorri-Vigneau, F. Feuillet, L. Wainstein, et al.European Journal of Clinical Pharmacology 69 (11) 1965 (2013)
https://doi.org/10.1007/s00228-013-1557-x
Addiction médicamenteuse : quelles données pour évaluer et prévenir ?
Maryse Lapeyre-MestrePsychotropes Vol. 19 (1) 65 (2013)
https://doi.org/10.3917/psyt.191.0065
Identification of abuse and dependence cases through a hospital database
A Daveluy, G Miremont‐Salamé, A Kostrzewa, A Couret, L Lacoin, C Lecomte, N Moore, V Gilleron and F HaramburuPharmacoepidemiology and Drug Safety 21 (12) 1344 (2012)
https://doi.org/10.1002/pds.3369
Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey
Elisabeth Frauger, Sandra Nordmann, Veronica Orleans, Vincent Pradel, Vanessa Pauly, Xavier Thirion and Joëlle MicallefFundamental & Clinical Pharmacology 26 (4) 549 (2012)
https://doi.org/10.1111/j.1472-8206.2011.00950.x
Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network
Elisabeth Frauger, Vanessa Pauly, Vincent Pradel, Frank Rouby, Jocelyne Arditti, Xavier Thirion, Maryse Lapeyre Mestre and Joëlle MicallefFundamental & Clinical Pharmacology 25 (5) 633 (2011)
https://doi.org/10.1111/j.1472-8206.2010.00882.x
Les systèmes d’évaluation de l’abus et de la dépendance des médicaments psychoactifs
Sandra Nordmann, Elisabeth Frauger, Vanessa Pauly, et al.Therapies 66 (3) 263 (2011)
https://doi.org/10.2515/therapie/2011045
Comparaison de la consommation de benzodiazépines selon le type d'usage de la buprénorphine dans une cohorte de nouveaux usagers
M Biboulet, M Lapeyre-Mestre and V. GardettePratiques et Organisation des Soins Vol. 41 (3) 205 (2010)
https://doi.org/10.3917/pos.413.0205
Evaluation of Abuse and Dependence on Drugs Used for Self-Medication
Ludivine Orriols, Julia Gaillard, Maryse Lapeyre-Mestre and Anne RoussinDrug Safety 32 (10) 859 (2009)
https://doi.org/10.2165/11316590-000000000-00000
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
Elisabeth Frauger, Vanessa Pauly, Xavier Thirion, et al.International Clinical Psychopharmacology 24 (6) 318 (2009)
https://doi.org/10.1097/YIC.0b013e328330ae4b